Impact Factor
4.57
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
10.55
3,141 total citations
h5-index
71
h5 depth signal
Cited share
74.0%
231 of 312
Total citations
3,141
Citation footprint
Metric signal
9.93
External metric anchor
Self-citation
0.3%
10 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
532
China
152
United Kingdom
130
Germany
98
France
74
Citing Fields of Research
Immunology
245
Neurodegenerative Disorders
105
Genetics & Genomics
95
Cancer, Autophagy & Apoptosis
88
Stem Cell Biology
87
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,239
Articles tracked across the journal lifetime
Indexed publication set
312
231 cited publications
Last 12 months
144
12.0 publications/month
Open access share
24.3%
35 OA publications in the last year
Leading citing country
United States
532 citing publications
Leading citing field
Immunology
245 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v7n1, Jan. 2001-
v7n1, Jan. 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Cancer, Autophagy & Apoptosis
Neurodegenerative Disorders
Oncology
Inflammatory Bowel Diseases & Infections
Musculoskeletal Disorders
Broad Categories
Molecular Biology
Nutrition & Dietetics
Cancer, Autophagy & Apoptosis
Neurodegenerative Disorders
Immunology
Musculoskeletal Disorders
Inflammatory Bowel Diseases & Infections
MeSH Descriptors
Clinical Medicine
Molecular Biology
Therapeutics
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.molmed.2026.09.016
Open DOI
Compartmentalized coenzyme A and ferroptosis vulnerability in PKAN and CoPAN
02
DOI 10.1016/j.molmed.2026.09.014
Open DOI
Degradation-coupled antibody conjugates for precision cancer therapy
03
DOI 10.1016/j.molmed.2026.09.010
Open DOI
Advances in modeling chromosomal aberrations to recapitulate genomic rearrangements
04
DOI 10.1016/j.molmed.2026.09.015
Open DOI
Disarming CH25H to clear α-synuclein
05
DOI 10.1016/s1471-4914(26)00239-x
Open DOI
Subscription and Copyright Information
06
DOI 10.1016/s1471-4914(26)00236-4
Open DOI
Advisory Board and Contents
07
DOI 10.1016/j.molmed.2026.09.008
Open DOI
Mesenchymal stem cells in bone regeneration: an organellar perspective
08
DOI 10.1016/j.molmed.2026.09.009
Open DOI
Predicting outcomes in oncogenic HPV infection: are we there yet?
09
DOI 10.1016/j.molmed.2026.09.012
Open DOI
What determines skin wound regeneration or scar healing?
10
DOI 10.1016/j.molmed.2026.09.013
Open DOI
What determines premalignant fate? A tale of stromal–epithelial crosstalk
Bibliographical & Catalog Notes
Title from cover.
Available also by subscription via the World Wide Web.